Information about the shortage of the medicinal product Neotigason 25 mg capsules (acitretin)
26.07.2012
Agmar d.o.o., the marketing authorisation holder has informed the Agency for Medicinal Products and Medical Devices about the shortage of the aforementioned product on the croatian market. This medicine has been used for the treatment of dermal diseases incuding psoriasis, ichthyosis and keratosis (Darier's disease). The reason for that shortage are production difficulties due to which the manufacturer Cenexi, Fontenay-Sous-Bois, France can not deliver the aforementioned medicine. On the 3rd July 2012, HALMED informed on its webpages about the shortage of the medicinal product Neotigason 10 mg capsules.
The normalisation of the market supply of the medicinal product Neotigason 25 mg capsules is expected in September 2012.
The public will be promptly informed of any new information about the shortage of the medicinal product Neotigason 25 mg capsules.
